Friday, August 21, 2009

MONOVISC Approved for Canadian Market

Chris Reidy of reports that Anika Therapeutics Inc. said it has received regulatory approval to distribute a treatment for osteoarthritis of the knee in Canada.

The treatment is MONOVISC, a single injection viscosupplement for the treatment of osteoarthritis of the knee, Bedford-based Anika said in a press release.

"MONOVISC has been broadly available in the European Union since the second quarter of 2008," said the Anika press release, which noted that the company is moving forward on its goal to receive approval for MONOVISC in the United States.

How long until the United States has MONOVISC available to patients?

Share this article with your social network, just click below to share now!

No comments :

Post a Comment